Gene · 10076
Papers2,589
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,589
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Stable expression of shRNA for the control of recombinant adenovirus replication. | Braz J Med Biol Res | 2023 | 37493770 | PubTator, text mining | PubMed |
| Cas phosphorylation regulates focal adhesion assembly. | Elife | 2023 | 37489578 | PubTator, text mining | PubMed |
| Harnessing the potential of lipid nanoparticles for the delivery of chemically modified siRNA to combat hepatic adenovirus infection. | Mol Ther Nucleic Acids | 2023 | 37449043 | PubTator, text mining | PubMed |
| RETRACTED: Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC). | Int J Mol Sci | 2023 | 37445722 | PubTator, text mining | PubMed |
| Targeted inhibition of PTPN22 is a novel approach to alleviate osteogenic responses in aortic valve interstitial cells and aortic valve lesions in mice. | BMC Med | 2023 | 37443055 | PubTator, text mining | PubMed |
| Which spontaneous breathing trial to predict effort to breathe after extubation according to five critical illnesses: the cross-over GLOBAL WEAN study protocol. | BMJ Open | 2023 | 37438068 | PubTator, text mining | PubMed |
| Fragment-Based Discovery of Novel VE-PTP Inhibitors Using Orthogonal Biophysical Techniques. | Biochemistry | 2023 | 37414577 | PubTator, text mining | PubMed |
| Regulation, targets and functions of CSK. | Front Cell Dev Biol | 2023 | 37397251 | PubTator, text mining | PubMed |
| Clonal evolution in tyrosine kinase inhibitor-resistance: lessons from in vitro-models. | Front Oncol | 2023 | 37384296 | PubTator, text mining | PubMed |
| A Conserved Local Structural Motif Controls the Kinetics of PTP1B Catalysis. | J Chem Inf Model | 2023 | 37378552 | PubTator, text mining | PubMed |
| A Phase 1 Two-Arm, Randomized, Double-Blind, Active-Controlled Study of Live, Oral Plasmid-Derived Adenovirus Type 4 and Type 7 Vaccines in Seronegative Adults. | Vaccines (Basel) | 2023 | 37376480 | PubTator, text mining | PubMed |
| Mast Cells as a Potential Target of Molecular Hydrogen in Regulating the Local Tissue Microenvironment. | Pharmaceuticals (Basel) | 2023 | 37375765 | PubTator, text mining | PubMed |
| Methyl Syringate Stimulates Glucose Uptake by Inhibiting Protein Tyrosine Phosphatases Relevant to Insulin Resistance. | Life (Basel) | 2023 | 37374154 | PubTator, text mining | PubMed |
| JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus. | Genes (Basel) | 2023 | 37372319 | PubTator, text mining | PubMed |
| Hypertrophic cardiomyopathy in an adult patient with Noonan syndrome with multiple lentigines. | Clin Case Rep | 2023 | 37361648 | PubTator, text mining | PubMed |
| Exploring Allosteric Inhibitors of Protein Tyrosine Phosphatases Through High-Throughput Screening. | Methods Mol Biol | 2023 | 37355550 | PubTator, text mining | PubMed |
Human adenovirus DNA polymerase is evolutionarily and functionally associated with human telomerase reverse transcriptase based on in silico molecular characterization that implicate abacavir and zidovudine. | Front Bioinform | 2023 | 37351013 | PubTator, text mining | PubMed |
| A type II protein arginine methyltransferase regulates merozoite invasion in Plasmodium falciparum. | Commun Biol | 2023 | 37349497 | PubTator, text mining | PubMed |
| Lipid nanoparticle-encapsulated, chemically modified anti-adenoviral siRNAs inhibit hepatic adenovirus infection in immunosuppressed Syrian hamsters. | Mol Ther Nucleic Acids | 2023 | 37346978 | PubTator, text mining | PubMed |
| N-Heteroacenes as an Organic Gain Medium for Room-Temperature Masers. | Chem Mater | 2023 | 37332679 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10076/papers?page=11